Myungmoon Bondubejeong

Adult dose

1 tablet orally, once a day.

This drug may increase the risk of blood clots in the bloodstream; therefore, patients with a history of thrombosis or those at high risk for thrombosis need careful assessment before administration. If a condition limiting movement occurs during treatment, use should be immediately discontinued, and it can be restarted after symptoms improve. This drug is primarily metabolized in the liver, so its use is not recommended in patients with impaired liver function, and liver function test values should be regularly monitored. The use of this drug has not been approved for premenopausal women, so it should not be administered to them. Postmenopausal women with a history of cardiovascular disease or high risk factors should be cautious as the risk of fatal stroke may increase with administration. This medication should not be used for the prevention of cardiovascular diseases, and its safety has not been established when combined with other hormonal therapies, hence is not recommended. Pregnant women or those who might become pregnant and nursing mothers should not take this medication as it could be harmful to fetuses or newborns. Patients with a history of allergic reactions to this drug or its components, liver impairment, or unexplained uterine bleeding should not take this medication. This drug should also not be administered to patients with certain hereditary lactose intolerance. Patients with hypertriglyceridemia, impaired kidney function, or a history of kidney stones should be cautious when using this drug and monitor blood lipid levels, etc. During the intake of this drug, symptoms such as leg cramps, facial flushing due to vascular dilation, peripheral edema, cold symptoms, etc., may occur, and if unusual symptoms arise, medical consultation is necessary. When combined with other drugs, some substances may affect the absorption or metabolism of this medication, so it is important to inform healthcare providers of any medications being taken. This drug is not used in children or men, and although its safety and efficacy have been confirmed in the elderly, caution is still required during administration. In cases of overdose, symptoms such as dizziness, vomiting, and muscle cramps may appear, so the dosage must be strictly adhered to, and in emergency situations, immediate medical attention is required. Store this drug out of reach of children and be careful not to transfer it to other containers.

Serious side effects

• Hives
• severe swelling (edema)
• deep vein thrombosis
• pulmonary embolism
• retinal vein thrombosis
• superficial venous thrombophlebitis
• stroke
• thrombocytopenia
• elevated blood pressure
• migraines

Mild side effects

• Vasodilation (facial flushing)
• leg cramps
• cold symptoms
• peripheral edema
• slight decrease in platelet count
• moderate elevation of AST and/or ALT
• cholecystitis
• vaginal bleeding
• facial swelling
• heartburn

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its efficacy.

Appearance

Yellow round film-coated tablet

Package unit

30 tablets (10 tablets/PTP X3)